{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:22:01Z","timestamp":1791570121266,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ajog.2021.12.263","type":"journal-article","created":{"date-parts":[[2021,12,29]],"date-time":"2021-12-29T10:57:04Z","timestamp":1640775424000},"page":"764-772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Implementing pre-exposure prophylaxis for HIV prevention in women: the role of the obstetrician-gynecologist"],"prefix":"10.1016","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3164-4592","authenticated-orcid":false,"given":"Sharlay K.","family":"Butler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5519-5894","authenticated-orcid":false,"given":"Yasaswi","family":"Kislovskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Bunge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6094-1238","authenticated-orcid":false,"given":"Harold C.","family":"Wiesenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2021.12.263_bib2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/QAD.0000000000002084","article-title":"HIV and amenorrhea: a meta-analysis","volume":"33","author":"King","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.ajog.2021.12.263_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1067\/mob.2002.119776","article-title":"Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection","volume":"186","author":"Jamieson","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.12.263_bib4","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/01.AOG.0000245442.29969.5c","article-title":"Effects of human immunodeficiency virus on protracted amenorrhea and ovarian dysfunction","volume":"108","author":"Cejtin","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.12.263_bib5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0002-9378(95)90572-3","article-title":"Genital ulcer disease in women infected with human immunodeficiency virus","volume":"172","author":"LaGuardia","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.12.263_bib6","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/QAD.0000000000000298","article-title":"Estimating per-act HIV transmission risk: a systematic review","volume":"28","author":"Patel","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.ajog.2021.12.263_bib7","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/bmj.304.6830.809","article-title":"Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV","volume":"304","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2021.12.263_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/QAI.0b013e318202a9c4","article-title":"Estimated HIV incidence among high-risk heterosexuals in New York City, 2007","volume":"56","author":"Jenness","year":"2011","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajog.2021.12.263_bib9","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ije\/dyq057","article-title":"HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention","volume":"39","author":"Baggaley","year":"2010","journal-title":"Int J Epidemiol"},{"issue":"Suppl2","key":"10.1016\/j.ajog.2021.12.263_bib10","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1097\/QAI.0b013e3181fbcb38","article-title":"Structural interventions for HIV prevention in the United States","volume":"55","author":"Adimora","year":"2010","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajog.2021.12.263_bib11","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1007\/s10461-017-1965-5","article-title":"Structural interventions in HIV prevention: a taxonomy and descriptive systematic review","volume":"21","author":"Sipe","year":"2017","journal-title":"AIDS Behav"},{"key":"10.1016\/j.ajog.2021.12.263_bib12","doi-asserted-by":"crossref","first-page":"e307","DOI":"10.1016\/S2352-3018(16)30038-8","article-title":"Interventions to strengthen the HIV prevention cascade: a systematic review of reviews","volume":"3","author":"Krishnaratne","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ajog.2021.12.263_bib13","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1600693","article-title":"Antiretroviral therapy for the prevention of HIV-1 transmission","volume":"375","author":"Cohen","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2021.12.263_bib14","doi-asserted-by":"crossref","first-page":"E1350","DOI":"10.1503\/cmaj.180311","article-title":"Risk of sexual transmission of human immunodeficiency virus with antiretroviral therapy, suppressed viral load and condom use: a systematic review","volume":"190","author":"LeMessurier","year":"2018","journal-title":"CMAJ"},{"key":"10.1016\/j.ajog.2021.12.263_bib15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00007435-199004000-00014","article-title":"Evaluation of the virus permeability of a new condom for women","volume":"17","author":"Drew","year":"1990","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ajog.2021.12.263_bib16","first-page":"CD003255","article-title":"Condom effectiveness in reducing heterosexual HIV transmission","author":"Weller","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2021.12.263_bib17","author":"Hunt"},{"key":"10.1016\/j.ajog.2021.12.263_bib18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40262-014-0148-z","article-title":"Pharmacokinetics of antiretrovirals in genital secretions and anatomic sites of HIV transmission: implications for HIV prevention","volume":"53","author":"Trezza","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajog.2021.12.263_bib19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(20)31065-5","article-title":"Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCover): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial","volume":"396","author":"Mayer","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2021.12.263_bib20","series-title":"US Public Health Service: preexposure prophylaxis for the prevention of HIV infection in the United States\u20142017 update: a clinical practice guideline","year":"2018"},{"key":"10.1016\/j.ajog.2021.12.263_bib21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2021.12.263_bib22","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2021.12.263_bib23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana","volume":"367","author":"Thigpen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2021.12.263_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women","volume":"372","author":"Marrazzo","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2021.12.263_bib25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women","volume":"367","author":"Van Damme","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2021.12.263_bib26","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/QAI.0000000000001160","article-title":"Brief report: preventing HIV-1 infection in women using oral preexposure prophylaxis: a meta-analysis of current evidence","volume":"73","author":"Hanscom","year":"2016","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajog.2021.12.263_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/infdis\/jiw077","article-title":"A\u00a0translational pharmacology approach to predicting outcomes of preexposure prophylaxis against HIV in men and women using tenofovir disoproxil fumarate with or without emtricitabine","volume":"214","author":"Cottrell","year":"2016","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajog.2021.12.263_bib28","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1089\/jwh.2018.7353","article-title":"Factors affecting pre-exposure prophylaxis implementation for women in the United States: a systematic review","volume":"28","author":"Bradley","year":"2019","journal-title":"J\u00a0Womens Health (Larchmt)"},{"key":"10.1016\/j.ajog.2021.12.263_bib29","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2021.12.263_bib30","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(13)61140-X","article-title":"HIV pre-exposure prophylaxis in injecting drug users","volume":"381","author":"Karim","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2021.12.263_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/infdis\/jiy113","article-title":"Increased risk of HIV acquisition among women throughout pregnancy and during the postpartum period: a prospective per-coital-act analysis among women with HIV-infected partners","volume":"218","author":"Thomson","year":"2018","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajog.2021.12.263_bib32","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1056\/NEJM199908053410602","article-title":"Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group","volume":"341","author":"Garcia","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2021.12.263_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/QAD.0000000000001313","article-title":"Tenofovir disoproxil fumarate safety for women and their infants during pregnancy and breastfeeding","volume":"31","author":"Mofenson","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.ajog.2021.12.263_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijid.2019.07.023","article-title":"Guides concerning tenofovir exposure via breastfeeding: a comparison of drug dosages by developmental stage","volume":"87","author":"Hu","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ajog.2021.12.263_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002132","article-title":"Pre-exposure prophylaxis use by breastfeeding HIV-uninfected women: a prospective short-term study of antiretroviral excretion in breast milk and infant absorption","volume":"13","author":"Mugwanya","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajog.2021.12.263_bib38","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.annepidem.2018.05.003","article-title":"Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race\/ethnicity, United States, 2015","volume":"28","author":"Smith","year":"2018","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ajog.2021.12.263_bib39","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.15585\/mmwr.mm6741a3","article-title":"HIV preexposure prophylaxis, by race and ethnicity - United States, 2014-2016","volume":"67","author":"Huang","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajog.2021.12.263_bib41","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.2105\/AJPH.2017.304061","article-title":"Integrating HIV preexposure prophylaxis (PrEP) into routine preventive health care to avoid exacerbating disparities","volume":"107","author":"Calabrese","year":"2017","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ajog.2021.12.263_bib42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1037\/a0032694","article-title":"A\u00a0pandemic of the poor: social disadvantage and the U.S. HIV epidemic","volume":"68","author":"Pellowski","year":"2013","journal-title":"Am Psychol"},{"key":"10.1016\/j.ajog.2021.12.263_bib43","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/infdis\/jiz416","article-title":"Hidden in plain sight: identifying women living in the United States who could benefit from HIV preexposure prophylaxis","volume":"222","author":"Ojikutu","year":"2020","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ajog.2021.12.263_bib44","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1007\/s10461-018-2184-4","article-title":"Improving PrEP implementation through multilevel interventions: a synthesis of the literature","volume":"22","author":"Pinto","year":"2018","journal-title":"AIDS Behav"},{"key":"10.1016\/j.ajog.2021.12.263_bib45","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/QAI.0000000000001950","article-title":"Brief report: PrEP eligibility among at-risk women in the Southern United States: associated factors, awareness, and acceptability","volume":"80","author":"Patel","year":"2019","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajog.2021.12.263_bib46","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/09540121.2016.1234679","article-title":"Predictors of HIV-related risk perception and PrEP acceptability among young adult female family planning patients","volume":"29","author":"Garfinkel","year":"2017","journal-title":"AIDS Care"},{"key":"10.1016\/j.ajog.2021.12.263_bib47","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1089\/apc.2011.0202","article-title":"HIV risk perception and preexposure prophylaxis interest among a heterosexual population visiting a sexually transmitted infection clinic","volume":"26","author":"Khawcharoenporn","year":"2012","journal-title":"AIDS Patient Care STDs"},{"key":"10.1016\/j.ajog.2021.12.263_bib48","first-page":"1","article-title":"Women want pre-exposure prophylaxis but are advised against it by their HIV-positive counterparts","volume":"6","author":"Goparaju","year":"2015","journal-title":"J\u00a0AIDS Clin Res"},{"key":"10.1016\/j.ajog.2021.12.263_bib49","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1097\/QAI.0000000000002558","article-title":"Integrating HIV preexposure prophylaxis with community-based syringe services for women who inject drugs: results from the Project SHE Demonstration Study","volume":"86","author":"Roth","year":"2021","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajog.2021.12.263_bib50","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/QAI.0000000000001605","article-title":"Correlates of linkage to HIV preexposure prophylaxis among HIV-testing clients","volume":"77","author":"Flash","year":"2018","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajog.2021.12.263_bib51","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","article-title":"Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review","volume":"37","author":"Mayer","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.ajog.2021.12.263_bib52","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.contraception.2015.12.018","article-title":"United States family planning providers\u2019 knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey","volume":"93","author":"Seidman","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2021.12.263_bib53","doi-asserted-by":"crossref","first-page":"185S","DOI":"10.1097\/01.AOG.0000558937.64362.d3","article-title":"Do you PrEP? Knowledge and practice among obstetrician and gynecologists in an inner city hospital [16Q]","volume":"133","author":"Kole","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.12.263_bib55","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/cid\/ciz046","article-title":"US guideline criteria for human immunodeficiency virus preexposure prophylaxis: clinical considerations and caveats","volume":"69","author":"Calabrese","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajog.2021.12.263_bib56","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/QAI.0000000000002042","article-title":"Current US guidelines for prescribing HIV pre-exposure prophylaxis (PrEP) disqualify many women who are at risk and motivated to use PrEP","volume":"81","author":"Calabrese","year":"2019","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajog.2021.12.263_bib57","unstructured":"Truvada (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use [Package insert]. https:\/\/www.gilead.com\/\u223c\/media\/files\/pdfs\/medicines\/hiv\/truvada\/truvada_pi.pdf."},{"key":"10.1016\/j.ajog.2021.12.263_bib58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/COH.0000000000000207","article-title":"Tenofovir-based oral preexposure prophylaxis prevents HIV infection among women","volume":"11","author":"Thomson","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.ajog.2021.12.263_bib59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/AOG.0000000000001455","article-title":"Integrating preexposure prophylaxis for human immunodeficiency virus prevention into Women\u2019s Health Care in the United States","volume":"128","author":"Seidman","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.12.263_bib60","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/COH.0000000000000220","article-title":"Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice","volume":"11","author":"Haberer","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.ajog.2021.12.263_bib61","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11904-019-00430-z","article-title":"A\u00a0review of telehealth innovations for HIV pre-exposure prophylaxis (PrEP)","volume":"16","author":"Touger","year":"2019","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.ajog.2021.12.263_bib62","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1016\/S2352-3018(19)30372-8","volume":"7","author":"Sch\u00fcrmann","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ajog.2021.12.263_bib65","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","article-title":"Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women","volume":"375","author":"Nel","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2021.12.263_bib66","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a vaginal ring containing dapivirine for HIV-1 prevention in women","volume":"375","author":"Baeten","year":"2016","journal-title":"N\u00a0Engl J Med"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821029586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821029586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:36:55Z","timestamp":1757590615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937821029586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0002937821029586"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2021.12.263","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementing pre-exposure prophylaxis for HIV prevention in women: the role of the obstetrician-gynecologist","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2021.12.263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}